CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Gentium

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

First marketed drug

Mar 30, 2016

First NDA

Mar 30, 2016

Last known activity

Mar 30, 2016

Acquired by Jazz Pharmaceuticals on Mar 31, 2014

Timeline

1990s

  1. Jan 1, 1993

    Gentium— Founded

2010s

  1. Mar 31, 2014

    Jazz Pharmaceuticals— Acquired By

  2. Mar 30, 2016

    defibrotide— NDA Organization

Indications

Approved for

Marketed drugs (1)

Details

Founded
Villa Guardia, IT Jan 1, 1993
First NDA
Mar 30, 2016
Last known activity
Mar 30, 2016

Designations held

  • Orphan drug
  • Fast track
  • Priority review